

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 7.82853934 |
| 2 | cilium or flagellum-dependent cell motility (GO:0001539) | 7.72877264 |
| 3 | tryptophan catabolic process (GO:0006569) | 6.75610253 |
| 4 | indole-containing compound catabolic process (GO:0042436) | 6.75610253 |
| 5 | indolalkylamine catabolic process (GO:0046218) | 6.75610253 |
| 6 | indolalkylamine metabolic process (GO:0006586) | 6.50236396 |
| 7 | kynurenine metabolic process (GO:0070189) | 6.42327438 |
| 8 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 6.23303673 |
| 9 | regulation of hippo signaling (GO:0035330) | 5.78892278 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.51446788 |
| 11 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.50483180 |
| 12 | regulation of gene silencing by miRNA (GO:0060964) | 5.50483180 |
| 13 | regulation of gene silencing by RNA (GO:0060966) | 5.50483180 |
| 14 | tachykinin receptor signaling pathway (GO:0007217) | 5.25745470 |
| 15 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.81592621 |
| 16 | indole-containing compound metabolic process (GO:0042430) | 4.73511170 |
| 17 | photoreceptor cell maintenance (GO:0045494) | 4.64561005 |
| 18 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.59947505 |
| 19 | respiratory tube development (GO:0030323) | 4.54645310 |
| 20 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.53987358 |
| 21 | auditory receptor cell stereocilium organization (GO:0060088) | 4.52903595 |
| 22 | NAD biosynthetic process (GO:0009435) | 4.48115767 |
| 23 | benzene-containing compound metabolic process (GO:0042537) | 4.47046903 |
| 24 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 4.46267223 |
| 25 | behavioral response to ethanol (GO:0048149) | 4.46042896 |
| 26 | reflex (GO:0060004) | 4.43802678 |
| 27 | histone H4-K12 acetylation (GO:0043983) | 4.40208085 |
| 28 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 4.27049187 |
| 29 | serotonin metabolic process (GO:0042428) | 4.15536228 |
| 30 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.12051628 |
| 31 | detection of light stimulus involved in visual perception (GO:0050908) | 4.12051628 |
| 32 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.10248623 |
| 33 | protein K48-linked deubiquitination (GO:0071108) | 4.08897951 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 3.95357804 |
| 35 | cellular biogenic amine catabolic process (GO:0042402) | 3.87330468 |
| 36 | amine catabolic process (GO:0009310) | 3.87330468 |
| 37 | detection of mechanical stimulus (GO:0050982) | 3.77148283 |
| 38 | flavonoid metabolic process (GO:0009812) | 3.75767833 |
| 39 | primary amino compound metabolic process (GO:1901160) | 3.71889541 |
| 40 | phospholipid translocation (GO:0045332) | 3.68867572 |
| 41 | lipid translocation (GO:0034204) | 3.68867572 |
| 42 | positive regulation of developmental pigmentation (GO:0048087) | 3.67291551 |
| 43 | righting reflex (GO:0060013) | 3.66176950 |
| 44 | regulation of pigment cell differentiation (GO:0050932) | 3.64363462 |
| 45 | thyroid hormone metabolic process (GO:0042403) | 3.63872253 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 3.63036843 |
| 47 | neural tube formation (GO:0001841) | 3.59571444 |
| 48 | aromatic amino acid family catabolic process (GO:0009074) | 3.56575497 |
| 49 | regulation of acrosome reaction (GO:0060046) | 3.55859756 |
| 50 | behavioral response to nicotine (GO:0035095) | 3.55418921 |
| 51 | snRNA transcription (GO:0009301) | 3.54266110 |
| 52 | regulation of skeletal muscle contraction (GO:0014819) | 3.53457531 |
| 53 | response to misfolded protein (GO:0051788) | 3.49527702 |
| 54 | ketone body metabolic process (GO:1902224) | 3.45975289 |
| 55 | inner ear receptor stereocilium organization (GO:0060122) | 3.43320843 |
| 56 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.40784179 |
| 57 | cellular response to sterol (GO:0036315) | 3.38369828 |
| 58 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.37789525 |
| 59 | opioid receptor signaling pathway (GO:0038003) | 3.36833852 |
| 60 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.36790862 |
| 61 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.36790862 |
| 62 | xenobiotic catabolic process (GO:0042178) | 3.32751301 |
| 63 | negative regulation of complement activation (GO:0045916) | 3.32531221 |
| 64 | membrane depolarization during action potential (GO:0086010) | 3.32434799 |
| 65 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.27105975 |
| 66 | sphingoid metabolic process (GO:0046519) | 3.25417865 |
| 67 | cytokine biosynthetic process (GO:0042089) | 3.21330829 |
| 68 | regulation of establishment of cell polarity (GO:2000114) | 3.21056660 |
| 69 | sulfation (GO:0051923) | 3.17991127 |
| 70 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.15662034 |
| 71 | regulation of sarcomere organization (GO:0060297) | 3.15103931 |
| 72 | cilium movement (GO:0003341) | 3.14062565 |
| 73 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.13595010 |
| 74 | neuronal action potential (GO:0019228) | 3.11667990 |
| 75 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.09984725 |
| 76 | protein K63-linked deubiquitination (GO:0070536) | 3.09845261 |
| 77 | oxidative demethylation (GO:0070989) | 3.09614748 |
| 78 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 3.07129955 |
| 79 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 3.07129955 |
| 80 | response to nitrosative stress (GO:0051409) | 3.06845667 |
| 81 | inner cell mass cell proliferation (GO:0001833) | 3.06148526 |
| 82 | dicarboxylic acid catabolic process (GO:0043649) | 3.04598907 |
| 83 | positive regulation of vasculogenesis (GO:2001214) | 2.96611574 |
| 84 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.96163511 |
| 85 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 2.95981529 |
| 86 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.93011128 |
| 87 | negative regulation of protein activation cascade (GO:2000258) | 2.88972478 |
| 88 | establishment of protein localization to Golgi (GO:0072600) | 2.88277267 |
| 89 | gamma-aminobutyric acid transport (GO:0015812) | 2.87228658 |
| 90 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.83975009 |
| 91 | drug catabolic process (GO:0042737) | 2.83439587 |
| 92 | retinal cone cell development (GO:0046549) | 2.81639649 |
| 93 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.78882550 |
| 94 | cellular response to ethanol (GO:0071361) | 2.78809060 |
| 95 | regulation of vasculogenesis (GO:2001212) | 2.76787182 |
| 96 | one-carbon compound transport (GO:0019755) | 2.75242810 |
| 97 | skeletal muscle tissue regeneration (GO:0043403) | 2.72084551 |
| 98 | striated muscle atrophy (GO:0014891) | 2.71806942 |
| 99 | response to caffeine (GO:0031000) | 2.70001059 |
| 100 | L-methionine biosynthetic process (GO:0071265) | 2.69826394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.70601152 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.63351867 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.40267421 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.99838798 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.75852206 |
| 6 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.56054309 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.35980521 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30852313 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.24992085 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.17700182 |
| 11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.17374736 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.16389291 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.08510359 |
| 14 | STAT3_23295773_ChIP-Seq_U87_Human | 2.05256963 |
| 15 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.01477887 |
| 16 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.99957448 |
| 17 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98533649 |
| 18 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.93882904 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.92666807 |
| 20 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88324151 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86708354 |
| 22 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.81865372 |
| 23 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.80449373 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.78949832 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77552139 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.76693372 |
| 27 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.73379089 |
| 28 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.69966833 |
| 29 | TCF4_23295773_ChIP-Seq_U87_Human | 1.67424561 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61509227 |
| 31 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.53959400 |
| 32 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.52674081 |
| 33 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52674081 |
| 34 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.50444585 |
| 35 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.50444585 |
| 36 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.49960869 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49073645 |
| 38 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.48394552 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47988890 |
| 40 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47841758 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47505355 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45129356 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44021254 |
| 44 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43191188 |
| 45 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.42851770 |
| 46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.42255582 |
| 47 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40368903 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39025149 |
| 49 | RXR_22108803_ChIP-Seq_LS180_Human | 1.38683705 |
| 50 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.34961217 |
| 51 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.33275921 |
| 52 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.32936115 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.32643817 |
| 54 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31686991 |
| 55 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.31233444 |
| 56 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.29549070 |
| 57 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.29407286 |
| 58 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23911117 |
| 59 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23911117 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22738443 |
| 61 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.22440857 |
| 62 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.22147386 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21889753 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21314074 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20659694 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19891750 |
| 67 | KDM2B_26808549_Chip-Seq_REH_Human | 1.19536469 |
| 68 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19228524 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.16471130 |
| 70 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.13562799 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12353736 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12312294 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12036891 |
| 74 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.11738776 |
| 75 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11386568 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.11241734 |
| 77 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.10886134 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10163598 |
| 79 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08513680 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07735475 |
| 81 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07540600 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07017299 |
| 83 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04817230 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04301044 |
| 85 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04048803 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03936184 |
| 87 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03543557 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02181644 |
| 89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01956890 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01689921 |
| 91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00266317 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99618330 |
| 93 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.99554329 |
| 94 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.98504663 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98473687 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98473687 |
| 97 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98448855 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98405206 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97364329 |
| 100 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95286586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 4.70189118 |
| 2 | MP0008057_abnormal_DNA_replication | 4.20035027 |
| 3 | MP0003195_calcinosis | 3.95813995 |
| 4 | MP0001501_abnormal_sleep_pattern | 3.82088295 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.23836000 |
| 6 | MP0003878_abnormal_ear_physiology | 3.00410265 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 3.00410265 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.94364782 |
| 9 | MP0003879_abnormal_hair_cell | 2.91982218 |
| 10 | MP0001485_abnormal_pinna_reflex | 2.87246244 |
| 11 | MP0003646_muscle_fatigue | 2.85794754 |
| 12 | MP0005670_abnormal_white_adipose | 2.85498908 |
| 13 | MP0009046_muscle_twitch | 2.82596320 |
| 14 | MP0005551_abnormal_eye_electrophysiolog | 2.61158695 |
| 15 | MP0003045_fibrosis | 2.56649745 |
| 16 | MP0002736_abnormal_nociception_after | 2.54161573 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.43002845 |
| 18 | MP0004043_abnormal_pH_regulation | 2.29906453 |
| 19 | MP0006054_spinal_hemorrhage | 2.25720141 |
| 20 | MP0003136_yellow_coat_color | 2.20634008 |
| 21 | MP0009053_abnormal_anal_canal | 1.99797321 |
| 22 | MP0003252_abnormal_bile_duct | 1.98166420 |
| 23 | MP0010386_abnormal_urinary_bladder | 1.98063505 |
| 24 | MP0005410_abnormal_fertilization | 1.91044549 |
| 25 | MP0006276_abnormal_autonomic_nervous | 1.90140770 |
| 26 | MP0009745_abnormal_behavioral_response | 1.75768431 |
| 27 | MP0000538_abnormal_urinary_bladder | 1.73313207 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.55148010 |
| 29 | MP0002168_other_aberrant_phenotype | 1.51091583 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.50992434 |
| 31 | MP0002928_abnormal_bile_duct | 1.50603950 |
| 32 | MP0005310_abnormal_salivary_gland | 1.49712989 |
| 33 | MP0000427_abnormal_hair_cycle | 1.44917973 |
| 34 | MP0001664_abnormal_digestion | 1.41179073 |
| 35 | MP0000230_abnormal_systemic_arterial | 1.39846906 |
| 36 | MP0008961_abnormal_basal_metabolism | 1.36314671 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.35714557 |
| 38 | MP0001970_abnormal_pain_threshold | 1.35685406 |
| 39 | MP0001486_abnormal_startle_reflex | 1.32670628 |
| 40 | MP0000383_abnormal_hair_follicle | 1.31148032 |
| 41 | MP0003633_abnormal_nervous_system | 1.29703154 |
| 42 | MP0002272_abnormal_nervous_system | 1.29580108 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.28783643 |
| 44 | MP0002064_seizures | 1.27936872 |
| 45 | MP0008872_abnormal_physiological_respon | 1.26419834 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.23119031 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.21576660 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.20408920 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.20070577 |
| 50 | MP0001963_abnormal_hearing_physiology | 1.15605563 |
| 51 | MP0002229_neurodegeneration | 1.15255693 |
| 52 | MP0002876_abnormal_thyroid_physiology | 1.13808040 |
| 53 | MP0005253_abnormal_eye_physiology | 1.12714094 |
| 54 | MP0004130_abnormal_muscle_cell | 1.09907449 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.09548579 |
| 56 | MP0005085_abnormal_gallbladder_physiolo | 1.09003184 |
| 57 | MP0005647_abnormal_sex_gland | 1.07197646 |
| 58 | MP0003635_abnormal_synaptic_transmissio | 1.04047030 |
| 59 | MP0005360_urolithiasis | 1.02602817 |
| 60 | MP0000371_diluted_coat_color | 1.01710240 |
| 61 | MP0005503_abnormal_tendon_morphology | 1.00505850 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.00182686 |
| 63 | MP0004147_increased_porphyrin_level | 0.99944870 |
| 64 | MP0003698_abnormal_male_reproductive | 0.99885093 |
| 65 | MP0002693_abnormal_pancreas_physiology | 0.98279639 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 0.97803500 |
| 67 | MP0005266_abnormal_metabolism | 0.97244932 |
| 68 | MP0000026_abnormal_inner_ear | 0.94022739 |
| 69 | MP0005171_absent_coat_pigmentation | 0.93716250 |
| 70 | MP0004085_abnormal_heartbeat | 0.91096216 |
| 71 | MP0005595_abnormal_vascular_smooth | 0.90756147 |
| 72 | MP0001756_abnormal_urination | 0.88289232 |
| 73 | MP0005395_other_phenotype | 0.88236252 |
| 74 | MP0009764_decreased_sensitivity_to | 0.87099247 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.84455328 |
| 76 | MP0004742_abnormal_vestibular_system | 0.84293988 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.84221921 |
| 78 | MP0002090_abnormal_vision | 0.83611241 |
| 79 | MP0003631_nervous_system_phenotype | 0.83180943 |
| 80 | MP0006082_CNS_inflammation | 0.82109655 |
| 81 | MP0001661_extended_life_span | 0.81581233 |
| 82 | MP0001984_abnormal_olfaction | 0.81541235 |
| 83 | MP0000470_abnormal_stomach_morphology | 0.81435764 |
| 84 | MP0002102_abnormal_ear_morphology | 0.80406338 |
| 85 | MP0002557_abnormal_social/conspecific_i | 0.78830328 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.77174782 |
| 87 | MP0003959_abnormal_lean_body | 0.76753376 |
| 88 | MP0005275_abnormal_skin_tensile | 0.74984636 |
| 89 | MP0002938_white_spotting | 0.73757800 |
| 90 | MP0003119_abnormal_digestive_system | 0.72433647 |
| 91 | MP0001873_stomach_inflammation | 0.69756156 |
| 92 | MP0004142_abnormal_muscle_tone | 0.69684518 |
| 93 | MP0003868_abnormal_feces_composition | 0.68604056 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.68420062 |
| 95 | MP0003941_abnormal_skin_development | 0.66983067 |
| 96 | MP0005195_abnormal_posterior_eye | 0.66285470 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.63844737 |
| 98 | MP0002063_abnormal_learning/memory/cond | 0.62561542 |
| 99 | MP0001440_abnormal_grooming_behavior | 0.60330133 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.60006718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 5.90748838 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.65986320 |
| 3 | Genetic anticipation (HP:0003743) | 5.37557634 |
| 4 | Attenuation of retinal blood vessels (HP:0007843) | 5.07649935 |
| 5 | Ileus (HP:0002595) | 5.00602564 |
| 6 | Central scotoma (HP:0000603) | 4.69176468 |
| 7 | Pancreatic cysts (HP:0001737) | 4.68766857 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.65895125 |
| 9 | Congenital sensorineural hearing impairment (HP:0008527) | 4.62314712 |
| 10 | Gaze-evoked nystagmus (HP:0000640) | 4.62159120 |
| 11 | Clumsiness (HP:0002312) | 4.49785190 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 4.35529578 |
| 13 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.31250616 |
| 14 | Dysmetric saccades (HP:0000641) | 3.91055796 |
| 15 | Cystic liver disease (HP:0006706) | 3.62201516 |
| 16 | True hermaphroditism (HP:0010459) | 3.47240541 |
| 17 | Pancreatic fibrosis (HP:0100732) | 3.43226749 |
| 18 | Abnormal ciliary motility (HP:0012262) | 3.40039751 |
| 19 | Facial diplegia (HP:0001349) | 3.33975952 |
| 20 | Congenital stationary night blindness (HP:0007642) | 3.33596711 |
| 21 | Scotoma (HP:0000575) | 3.29153099 |
| 22 | Decreased circulating renin level (HP:0003351) | 3.24416495 |
| 23 | Abnormality of binocular vision (HP:0011514) | 3.22414809 |
| 24 | Diplopia (HP:0000651) | 3.22414809 |
| 25 | Increased corneal curvature (HP:0100692) | 3.18904190 |
| 26 | Keratoconus (HP:0000563) | 3.18904190 |
| 27 | Abolished electroretinogram (ERG) (HP:0000550) | 3.07720786 |
| 28 | Abnormality of the renal cortex (HP:0011035) | 3.03149871 |
| 29 | Hyperventilation (HP:0002883) | 2.95516319 |
| 30 | Constricted visual fields (HP:0001133) | 2.89390629 |
| 31 | Focal seizures (HP:0007359) | 2.87427506 |
| 32 | Facial shape deformation (HP:0011334) | 2.75999412 |
| 33 | Potter facies (HP:0002009) | 2.75999412 |
| 34 | Protruding tongue (HP:0010808) | 2.74202394 |
| 35 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.71740361 |
| 36 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.70591074 |
| 37 | Preaxial foot polydactyly (HP:0001841) | 2.69454508 |
| 38 | Chronic hepatic failure (HP:0100626) | 2.60984076 |
| 39 | Enlarged kidneys (HP:0000105) | 2.57575599 |
| 40 | Abnormality of the renal medulla (HP:0100957) | 2.52178593 |
| 41 | Large for gestational age (HP:0001520) | 2.51769238 |
| 42 | Abnormal drinking behavior (HP:0030082) | 2.50454025 |
| 43 | Polydipsia (HP:0001959) | 2.50454025 |
| 44 | Thyroid-stimulating hormone excess (HP:0002925) | 2.48070709 |
| 45 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.46651016 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 2.46651016 |
| 47 | Hyperalaninemia (HP:0003348) | 2.46651016 |
| 48 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.44543593 |
| 49 | Absent/shortened dynein arms (HP:0200106) | 2.44543593 |
| 50 | Congenital hepatic fibrosis (HP:0002612) | 2.43088139 |
| 51 | Dialeptic seizures (HP:0011146) | 2.43075883 |
| 52 | Febrile seizures (HP:0002373) | 2.42792420 |
| 53 | Tubulointerstitial fibrosis (HP:0005576) | 2.39542594 |
| 54 | Absent speech (HP:0001344) | 2.38281132 |
| 55 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.33941923 |
| 56 | Sclerocornea (HP:0000647) | 2.32082181 |
| 57 | Absence seizures (HP:0002121) | 2.30582794 |
| 58 | Prostate neoplasm (HP:0100787) | 2.29703580 |
| 59 | Cerebellar dysplasia (HP:0007033) | 2.29624436 |
| 60 | Abnormality of macular pigmentation (HP:0008002) | 2.27888478 |
| 61 | Furrowed tongue (HP:0000221) | 2.26523001 |
| 62 | Fair hair (HP:0002286) | 2.26433208 |
| 63 | Medial flaring of the eyebrow (HP:0010747) | 2.24815217 |
| 64 | Progressive visual loss (HP:0000529) | 2.23335487 |
| 65 | Hypothermia (HP:0002045) | 2.21336622 |
| 66 | Difficulty walking (HP:0002355) | 2.20331226 |
| 67 | Abnormality of midbrain morphology (HP:0002418) | 2.19968417 |
| 68 | Molar tooth sign on MRI (HP:0002419) | 2.19968417 |
| 69 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.15287160 |
| 70 | Nephronophthisis (HP:0000090) | 2.11583984 |
| 71 | Tubular atrophy (HP:0000092) | 2.10402313 |
| 72 | Type II lissencephaly (HP:0007260) | 2.08875642 |
| 73 | Tubulointerstitial abnormality (HP:0001969) | 2.07425842 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.04921012 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.04921012 |
| 76 | Portal hypertension (HP:0001409) | 2.01562205 |
| 77 | Retinitis pigmentosa (HP:0000510) | 2.01454431 |
| 78 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.01238076 |
| 79 | Hypoplastic ischia (HP:0003175) | 1.99708834 |
| 80 | Proximal tubulopathy (HP:0000114) | 1.99098426 |
| 81 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.97979863 |
| 82 | Abnormality of the ischium (HP:0003174) | 1.97465085 |
| 83 | Polyuria (HP:0000103) | 1.96571320 |
| 84 | Poikiloderma (HP:0001029) | 1.96002252 |
| 85 | Decreased central vision (HP:0007663) | 1.92381976 |
| 86 | Postural instability (HP:0002172) | 1.91906028 |
| 87 | Spastic paraplegia (HP:0001258) | 1.91048612 |
| 88 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.89283109 |
| 89 | Abnormality of renin-angiotensin system (HP:0000847) | 1.88631407 |
| 90 | Impaired smooth pursuit (HP:0007772) | 1.87533349 |
| 91 | Severe visual impairment (HP:0001141) | 1.86351908 |
| 92 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.86149312 |
| 93 | Abnormality of the hepatic vasculature (HP:0006707) | 1.86013770 |
| 94 | Inability to walk (HP:0002540) | 1.84785150 |
| 95 | Congenital primary aphakia (HP:0007707) | 1.84291072 |
| 96 | Gait imbalance (HP:0002141) | 1.84028363 |
| 97 | Focal motor seizures (HP:0011153) | 1.82835397 |
| 98 | Small hand (HP:0200055) | 1.80854796 |
| 99 | Hyperkalemia (HP:0002153) | 1.80487663 |
| 100 | Opisthotonus (HP:0002179) | 1.77185655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADRBK2 | 3.75677978 |
| 2 | ACVR1B | 2.80854823 |
| 3 | BMPR1B | 2.80753749 |
| 4 | PIK3CG | 2.77678623 |
| 5 | INSRR | 2.34775497 |
| 6 | FRK | 12.3801447 |
| 7 | NTRK3 | 1.95566994 |
| 8 | OXSR1 | 1.72846042 |
| 9 | STK38L | 1.71904703 |
| 10 | TAOK3 | 1.71292623 |
| 11 | ADRBK1 | 1.61016966 |
| 12 | TIE1 | 1.56457430 |
| 13 | GRK1 | 1.53685291 |
| 14 | PINK1 | 1.46875298 |
| 15 | ZAK | 1.40829023 |
| 16 | TNK2 | 1.33491243 |
| 17 | STK39 | 1.29781408 |
| 18 | TGFBR1 | 1.20749537 |
| 19 | TEC | 1.20189965 |
| 20 | DAPK2 | 1.19347205 |
| 21 | MKNK2 | 1.12236903 |
| 22 | FER | 1.11637872 |
| 23 | CDK19 | 1.07831613 |
| 24 | KDR | 1.00572415 |
| 25 | WNK3 | 0.99310843 |
| 26 | STK38 | 0.98632459 |
| 27 | LATS1 | 0.96984777 |
| 28 | PRKCG | 0.93976334 |
| 29 | MAP3K7 | 0.91444817 |
| 30 | STK3 | 0.89525622 |
| 31 | PTK2B | 0.84292538 |
| 32 | ITK | 0.83706816 |
| 33 | PRKCE | 0.78243436 |
| 34 | TRPM7 | 0.76769367 |
| 35 | MYLK | 0.76709796 |
| 36 | PRKAA2 | 0.76395884 |
| 37 | NUAK1 | 0.69642671 |
| 38 | PIK3CA | 0.69375747 |
| 39 | MELK | 0.67771049 |
| 40 | KIT | 0.66471321 |
| 41 | TXK | 0.66172517 |
| 42 | CASK | 0.64087652 |
| 43 | CAMK2A | 0.63661026 |
| 44 | MAPKAPK3 | 0.58264087 |
| 45 | TLK1 | 0.56612276 |
| 46 | MAPK13 | 0.56076334 |
| 47 | WNK4 | 0.54177844 |
| 48 | NEK2 | 0.53952200 |
| 49 | MARK3 | 0.50412227 |
| 50 | MUSK | 0.49803204 |
| 51 | SGK2 | 0.49491224 |
| 52 | MAP3K4 | 0.49097578 |
| 53 | BTK | 0.47382416 |
| 54 | MAPK15 | 0.46586867 |
| 55 | MAPKAPK5 | 0.46417954 |
| 56 | IRAK1 | 0.45747242 |
| 57 | CHUK | 0.44967337 |
| 58 | IKBKB | 0.44684518 |
| 59 | PRKG2 | 0.43654507 |
| 60 | PRKACB | 0.40846982 |
| 61 | OBSCN | 0.40426785 |
| 62 | CDK3 | 0.39155247 |
| 63 | CAMK1 | 0.38760990 |
| 64 | DDR2 | 0.38505043 |
| 65 | PRKAA1 | 0.38384666 |
| 66 | MAPK11 | 0.38275534 |
| 67 | MKNK1 | 0.36819974 |
| 68 | NLK | 0.35302862 |
| 69 | PDK1 | 0.35252447 |
| 70 | PKN1 | 0.34472765 |
| 71 | SYK | 0.33487100 |
| 72 | AKT3 | 0.32401351 |
| 73 | PRKCB | 0.32366852 |
| 74 | PRKCH | 0.31415320 |
| 75 | CHEK2 | 0.31342085 |
| 76 | MAP2K1 | 0.31035408 |
| 77 | PRKCA | 0.30659730 |
| 78 | RPS6KA6 | 0.30446090 |
| 79 | GRK7 | 0.29554639 |
| 80 | MAP2K6 | 0.29464952 |
| 81 | FES | 0.29460741 |
| 82 | PRKACA | 0.29241598 |
| 83 | SGK223 | 0.26427470 |
| 84 | SGK494 | 0.26427470 |
| 85 | RPS6KA5 | 0.26190617 |
| 86 | BLK | 0.25013872 |
| 87 | MAP4K2 | 0.24828303 |
| 88 | PRKCQ | 0.23251961 |
| 89 | HCK | 0.22305901 |
| 90 | GRK5 | 0.21721516 |
| 91 | IGF1R | 0.21170095 |
| 92 | LCK | 0.20393350 |
| 93 | MAP3K9 | 0.20286676 |
| 94 | RPS6KA3 | 0.20119030 |
| 95 | EIF2AK3 | 0.19081366 |
| 96 | PRKG1 | 0.18279661 |
| 97 | MAPK7 | 0.17292086 |
| 98 | CSNK1D | 0.17238718 |
| 99 | AKT1 | 0.17232559 |
| 100 | LYN | 0.17217471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ABC transporters_Homo sapiens_hsa02010 | 3.53178283 |
| 2 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.21397323 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.99324677 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.54521397 |
| 5 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.34690487 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.32436990 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.30476871 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.21798818 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.07097378 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.05801837 |
| 11 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.03236399 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 2.01460039 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95204682 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85399718 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.85142027 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.74996372 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74519588 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72850258 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.72785268 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.67176372 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.59924490 |
| 22 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.59415320 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.59327201 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57995982 |
| 25 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.57749448 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.49168850 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47818825 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42568913 |
| 29 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39581743 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.35683609 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30858365 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.29288856 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.26861751 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26136886 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.17168851 |
| 36 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13389966 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.13310641 |
| 38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.12311294 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10117119 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05941586 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04225397 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03823897 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.02348924 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01434553 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01404628 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98262640 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95069557 |
| 48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.94878287 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89314995 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88114607 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86132340 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85934160 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84152909 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 0.83441268 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81674929 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.81015549 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.79356308 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79045720 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78351145 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77488707 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76966813 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 0.76798806 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75603005 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74904215 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72882533 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64182023 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64070897 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62789242 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59593882 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59395941 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.58227889 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.57887640 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.55561731 |
| 74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55153583 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54369043 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54270635 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52974520 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.52862513 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52337486 |
| 80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49902596 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49164295 |
| 82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44086081 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43435219 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43257266 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42003179 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41732381 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41089267 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40545823 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40514708 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40364258 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.39797750 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39245275 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38856022 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37998329 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37499077 |
| 96 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37021038 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36749904 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.36104799 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.35756122 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.35483727 |

